---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-148922"
form_type: "8-K"
ticker: "SPRY"
cik: "0001671858"
company_name: "ARS Pharmaceuticals, Inc."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T17:58:29.325137+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# ARS Pharma stockholders elect four Class II directors, ratify Ernst & Young as auditor

## Summary
- Elect directors Richard Lowenthal, Peter Kolchinsky, Brenton Saunders, Peter Thompson to 2028 term.
- Lowenthal receives 64.9M votes for, 3.0M withheld; Kolchinsky 55.8M for, 12.1M withheld.
- Saunders gets 56.2M for, 11.8M withheld; Thompson gets 61.8M for, 6.1M withheld.
- Broker non-votes on director election: 9.6M shares for each nominee.
- Auditor ratification passes with 77.3M for, 0.2M against; no broker non-votes.

## SEC filing metadata
- accession: 0001193125-25-148922
- form_type: 8-K
- ticker: SPRY
- cik: 0001671858
- company_name: ARS Pharmaceuticals, Inc.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671858/000119312525148922/0001193125-25-148922-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671858/000119312525148922/d15622d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-148922
- JSON: https://secwatch.observer/filing/0001193125-25-148922.json
- Plain text: https://secwatch.observer/filing/0001193125-25-148922.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.